DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Nefazodone Hydrochloride is a drug marketed by Ani Pharms Inc, Dr Reddys Labs Inc, Fosun Pharma, Ivax Sub Teva Pharms, Mylan, Roxane, Sun Pharm Inds Ltd, Teva, and Watson Labs. and is included in nine NDAs.
The generic ingredient in NEFAZODONE HYDROCHLORIDE is nefazodone hydrochloride. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the nefazodone hydrochloride profile page.
A generic version of NEFAZODONE HYDROCHLORIDE was approved as nefazodone hydrochloride by TEVA on September 16th, 2003.
Recent Clinical Trials for NEFAZODONE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|Maimonides Medical Center||Phase 2|
|Instituto Nacional de Salud Publica, Mexico||Phase 3|
|Laboratorios Grossman, S.A.||Phase 3|
Pharmacology for NEFAZODONE HYDROCHLORIDE
|Drug Class||Serotonin Reuptake Inhibitor |